182 related articles for article (PubMed ID: 33229808)
21. Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features.
Vogrig A; Gigli GL; Nilo A; Pessa ME; Volpetti S; Pegolo E; Valente M
J Neurovirol; 2020 Jun; 26(3):437-441. PubMed ID: 31807988
[TBL] [Abstract][Full Text] [Related]
22. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
23. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
24. To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy.
Scarpazza C; Prosperini L; De Rossi N; Moiola L; Sormani MP; Gerevini S; Capra R;
Ann Neurol; 2017 Nov; 82(5):697-705. PubMed ID: 29023856
[TBL] [Abstract][Full Text] [Related]
25. Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
Scarpazza C; Prosperini L; Mancinelli CR; De Rossi N; Lugaresi A; Capobianco M; Moiola L; Naldi P; Imberti L; Gerevini S; Capra R
J Neurol Sci; 2017 Jul; 378():233-237. PubMed ID: 28566170
[TBL] [Abstract][Full Text] [Related]
26. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS
Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652
[TBL] [Abstract][Full Text] [Related]
27. Steroids for PML-IRIS: a double-edged sword?
Berger JR
Neurology; 2009 Apr; 72(17):1454-5. PubMed ID: 19144930
[No Abstract] [Full Text] [Related]
28. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Hodel J; Bapst B; Outteryck O; Verclytte S; Deramecourt V; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
Mult Scler; 2018 Dec; 24(14):1902-1908. PubMed ID: 29343163
[TBL] [Abstract][Full Text] [Related]
29. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
30. Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
Wattjes MP; Verhoeff L; Zentjens W; Killestein J; van Munster ET; Barkhof F; van Eijk JJ
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1176-7. PubMed ID: 23695498
[No Abstract] [Full Text] [Related]
31. Progressive multifocal leukoencephalopathy therapy.
Clifford DB
J Neurovirol; 2015 Dec; 21(6):632-6. PubMed ID: 25227934
[TBL] [Abstract][Full Text] [Related]
32. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
33. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
34. A case of immune reconstitution syndrome complicating progressive multifocal leukoencephalopathy after kidney transplant: Clinical, pathological, and radiographic features.
Jackowiak E; Shah N; Chen H; Ojha A; Doyle J; Shepler A; Bogdanovich T; Silveira FP; Haidar G
Transpl Infect Dis; 2019 Oct; 21(5):e13162. PubMed ID: 31419376
[TBL] [Abstract][Full Text] [Related]
35. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
[TBL] [Abstract][Full Text] [Related]
37. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
38. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments.
Bernard-Valnet R; Moisset X; Maubeuge N; Lefebvre M; Ouallet JC; Roumier M; Lebrun-Frenay C; Ciron J; Biotti D; Clavelou P; Godeau B; Du Pasquier RA; Martin-Blondel G
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34728496
[TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leukoencephalopathy in an immunocompetent patient: A case report and review of literature.
Sriwastava S; Khan E; Khalid SH; Kaur A; Feizi P
J Med Virol; 2022 Jun; 94(6):2860-2869. PubMed ID: 34854099
[TBL] [Abstract][Full Text] [Related]
40. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
